Dror Ortho-Design, Inc.

DROR ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-625.1K $-638.7K $-555.9K $-653.5K $-759.3K $-576.1K $-1.1M $-1.8M
Depreciation & Amortization — — — — — — — —
Depreciation $1.3K $1.3K $1.2K $1.3K $1.2K $1.2K $1.2K $1.2K
Amortization — — — — — — — —
Stock-Based Compensation — — $0 $0 $16.0K $23.2K $391.3K $543.1K
Net Cash from Operating Activities $-304.8K $-404.3K $-649.0K $-424.1K $-485.4K $-499.6K $-563.1K $-691.2K
Investing Activities
Capital Expenditures — — — — — — $0 $0
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — — — — — $0 $0
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $375.0K $200.0K $650.0K $600.0K $200.0K $300.0K — —
Net Change in Cash $69.8K $-204.7K $-11.8K $175.9K $-285.4K $-199.6K $-593.8K $-691.2K
Free Cash Flow — — — — — — $-563.1K $-691.2K
← Newer Page 1 of 4 Older →